This comment is also inaccurate.
The review qualification relates to not seeing evidence to support the use of FV under new standard (essentially business model part of the test I'd expect). It isn't questioning the measurement of the assets under the policy they are applying. Also, once again, the mathematical differences between the two approaches isn't that significant IMO when considering the nature of the asset we are dealing with. Your comment is unfounded.
DYOR
- Forums
- ASX - By Stock
- PNC
- PNC
PNC, page-62
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNC (ASX) to my watchlist
(20min delay)
|
|||||
Last
62.0¢ |
Change
-0.010(1.59%) |
Mkt cap ! $73.69M |
Open | High | Low | Value | Volume |
61.0¢ | 62.0¢ | 60.0¢ | $109.8K | 179.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2071 | 62.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
62.5¢ | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 62500 | 0.480 |
1 | 36200 | 0.470 |
1 | 1816 | 0.465 |
1 | 20000 | 0.460 |
1 | 10000 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.490 | 47333 | 1 |
0.500 | 3000 | 1 |
0.505 | 432 | 1 |
0.510 | 85615 | 2 |
0.520 | 904 | 1 |
Last trade - 13.39pm 18/11/2024 (20 minute delay) ? |
Featured News
PNC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online